CELC

Latest SEC Filings & News for CELC

2 most recent filings and news items mentioning CELC. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/CELC/news?limit=20"

Pull CELC filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

CEL-SCI Corp engages ThinkEquity as exclusive placement agent for 2.5M share offering at $1.00 per share.

CEL-SCI Corporation has entered into a placement agency agreement with ThinkEquity LLC to act as exclusive placement agent for an offering of up to 2,500,000 shares of common stock at $1.00 per share. The offering will be conducted on a reasonable best efforts basis with closing

View filing at SEC.gov →

Celcuity's gedatolisib doubled survival benefit vs alpelisib in breast cancer trial

Celcuity announced positive Phase 3 VIKTORIA-1 trial results showing gedatolisib combination regimens reduced disease progression risk by 50% compared to alpelisib in PIK3CA mutant HR+/HER2- breast cancer patients. The results represent a potential major advancement for the compa

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.